As AbbVie's Risankizumab Looms, Sun Pushes To 'Maximize Time' Of Ilumya

 
• By Anju Ghangurde
Management
SUN IS KEEN TO PUSH AHEAD WITH PLANS FOR ILUMYA AS MORE COMPETITION LOOMS

More from Business

More from Scrip